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a  b  s  t  r  a  c  t
Parkinson’s  disease  is  a neurodegenerative  disorder  characterized  by  motor  impairment,  cognitive
decline  and  psychiatric  symptoms.  Schinus  terebinthifolius  Raddi,  Anacardiaceae,  had  been  studied  for
its anti-inﬂammatory  and  antioxidant  properties,  and  in  this  study,  the  stem  bark  was evaluated  for  the
neuroprotective  effects  on behavioral  and  biochemical  alterations  induced  by  administrations  of  rotenone
in rats.  Behavioral  evaluations  were  performed  using  open-ﬁeld  and  rotarod.  The  in vitro  and  in  vivo
antioxidant  activities  were  determined  by  the  DPPH  radical  scavenging  activity  and lipid  peroxidation
method  respectively.  The  administration  of  rotenone  (3 mg/kg,  s.c.)  produced  hypolocomotion,  increase  of
immobility  and  muscle  incoordination,  while  the treatment  with  S. terebinthifolius  stem  bark  extract  (150,
300 and  600  mg/kg  p.o.)  for  seven  days  prevented  rotenone-induced  dysfunctional  behavior.  Biochemicalotenone
chinus terebinthifolius analysis  of  the substantia  nigra,  striatum  and  cortex  revealed  that  rotenone  administration  signiﬁcantly
increased  lipid  peroxidation,  which  was  inhibited  by  treatment  with  all doses  of S.  terebinthifolius. The
results  suggested  neuroprotective  effect  of S. terebinthifolius  possibly  mediated  through  its  antioxidant
activity,  indicating  a  potential  therapeutic  beneﬁt  of this  species  in  the  treatment  of Parkinson’s  disease.
© 2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
The increase of elderly population has led to an increasing
ncidence of neurodegenerative diseases worldwide, leading, thus,
o the interest in studies for prevention and treatment of these
athologies. Natural constituents derived from plants are impor-
ant to investigate, since studies have shown that these compounds
xhibited a range of biological activities, with therapeutic potential,
or instance antioxidant and anti-inﬂammatory effects.
Parkinson’s disease (PD) is one if the major neurodegenerative
isorder in the entire world and is characterized by progres-
ive degeneration of dopamine-containing neurons that project
rom substantia nigra pars compacta to the striatum. Besides,
otor impairment (bradykinesia, rigidity, tremor at rest and dis-
urbances in balance), cognitive decline and psychiatric symptoms
like depression) are the cardinal symptoms of the pathology (Dutta
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E-mail: almir.wanderley@ufpe.br (A.G. Wanderley).
http://dx.doi.org/10.1016/j.bjp.2015.11.005
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraand Mohanakumar, 2015; Fernandez, 2015). Main mechanisms
have been proposed to explain the events culminating in neu-
ronal death in PD, which are associated with oxidative stress,
mitochondrial dysfunction, neuroinﬂammation and environmen-
tal exposures, like pesticides, contributing for the appearance of
behavioral and biochemical alterations (Dauer and Przedborski,
2003; Renaud et al., 2015). Several animal models have been
used to mimetize and elucidate the pathogenesis of PD, in special
rotenone, MPTP and 6-hydroxydopamine (Dauer and Przedborski,
2003; Blesa et al., 2012).
Rotenone (Derris sp., Fabaceae) has been a potent hydrophobic
pesticide and its environmental exposure mimics the clinical and
pathological features of PD, such as behavioral, biochemical and
pathological changes, providing a reproducible animal model for
PD (Betarbet et al., 2000). It provoked neurodegeneration via mul-
tiple mechanisms, mainly by inhibition of complex I, increase of
oxidative stress and induction of apoptosis (Zaitone et al., 2012;
von Wrangel et al., 2015).
Schinus terebinthifolius Raddi, Anacardiaceae, is a native plant of
South America (Corrêa, 1974). In Brazil it is popularly called Aroeira
 Ltda. All rights reserved.
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r Cabuí. In folk medicine, it has been used for the treatment of
lcers, respiratory problems, wounds and arthritis (Morton, 1978)
nd as an antiseptic, antiinﬂammatory and haemostatic (Medeiros
t al., 2007). Many of its properties or healing effects attributed
y folk medicine are associated to the presence of polyphenols in
he plant, which give the plant its antioxidant properties (Medeiros
t al., 2007; Abdou et al., 2015). The aim of this study was to investi-
ate the possible neuroprotective effects of S. terebinthifolius in the
ehavior activity and on the oxidative stress induced by rotenone
s experimental model of Parkinson’s disease in rats.
aterials and methods
lant material
Stem bark of Schinus terebinthifolius Raddi, Anacardiaceae, were
ollected in the remains of the Atlantic rainforest located in the
unicipality of Cabo de Santo Agostinho, Pernambuco, Brazil
etween February and April 2013 (8◦20′33′′ S and 34◦56′59′′ W).  A
oucher specimen was authenticated in the Department of Botany
f the Federal University of Pernambuco by the curator M.  Bar-
osa and was deposited at Geraldo Mariz Herbarium under record
◦. 8758. Extraction was performed by maceration and air dried,
nd 500 g of pulverized S. terebinthifolius bark was added to 1.0 l of
thanol 70% at room temperature, for 7 days, and was  occasionally
haken. In the laboratory, the crude ethanolic extract was evapo-
ated to dryness under reduced pressure for the total elimination
f alcohol, followed by lyophilization, yielding approximately 35 g
f dry residue. The lyophilized extract of S. terebinthifolius was  kept
t room temperature until use and suspended in distilled water.
igh performance liquid chromatography (HPLC) analysis
The main phytochemical markers (gallic acid, ellagic acid, cate-
hin and epicatechin) in S. terebinthifolius samples were analyzed
y way by way of liquid chromatography-diode array detection
LC-DAD) analysis using a Shimadzu system (LC-20AT) equipped
ith a photo diode array detector (SPD-M20A). The chromato-
raphic separation was performed using a Gemini RP-18 column
 m particle size and 250 mm × 4.60 mm i.d. (Phenomenex), pro-
ected by a guard column of the same material. A gradient elution
as performed by varying the proportion of Solvent A (0.5% acetic
cid in distilled water, v/v) and solvent B (methanol) at a ﬂow
ate of 0.8 ml/min following gradient program: 20–40% B (10 min),
0–60% B (10 min), 60% B (10 min), 60–40% B (10 min), and 40–20%
 (10 min). The dried extracts and standards were dissolved in
ethanol:water (20/80, v/v) and ﬁltered through a membrane of
.45 m (Millipore®, USA) prior to injection of 20 l. The peaks
f each marking on dry substance were identiﬁed by comparing
etention times and UV spectra of DAD.
nimals
Adult male Wistar rats (Rattus norvegicus var. albinus), age 3
onths and weighing between 250 and 300 g, were obtained from
he Department of Physiology and Pharmacology at the Federal
niversity of Pernambuco, Brazil. The animals were maintained
n standard environmental conditions (22 ± 2 ◦C, 12:12 h dark/light
ycle). Commercial food (Presence®, Purina, Brazil) and water were
vailable ad libitum.  All protocols were approved by the Animal
xperimentation Ethics Committee of the Federal University of
ernambuco, under license n◦. 23076.050131/2013-82 in accor-
ance with the National Institute of Health Guide for the Care and
se of Laboratory Animals.rmacognosia 26 (2016) 240–245 241
Drugs
Butylated hydroxytoluene (BHT), 2,2-diphenyl-1-
picrylhydrazyl (DPPH), malondialdehyde (MDA), thiobarbituric
acid (TBA), epinephrine, 1,1,3,3-tetrametoxipropane (TMP), Tween
80, DMSO and rotenone, were purchased from Sigma–Aldrich®
(St. Louis, MO,  USA). Rotenone was dissolved in sunﬂower oil one
day before beginning treatment. On subsequent days, solutions
remained in the refrigerator (4 ◦C). Sunﬂower oil was obtained in
local market.
Experimental groups
The animals were randomly divided into ﬁve experimental
groups (n = 10). Rats from Group 1 received water by gavage
(1 ml/kg) and 1 h later a subcutaneous (s.c.) administration of the
vehicle (90%, w/v  sunﬂower oil, +10% w/v DMSO) for seven days.
Group 2 also received water by gavage and rotenone (3 mg/kg, s.c.)
diluted in vehicle after 1 h during seven days. Groups 3, 4 and
5 received by gavage 150, 300 or 600 mg/kg of S. terebinthifolius,
respectively, suspended in water, and 1 h later were given them
rotenone (3 mg/kg, s.c.)  also during seven days. 24 h after the last
day of treatment, the rats were evaluated with behavioral tests and
biochemical assays (Linard-Medeiros et al., 2015).
Open ﬁeld test
The open ﬁeld test was  carried out to Broadhurst (1957) and
Bernardi and Palermo-Neto (1979). To quantify exploratory and
general locomotor activity, each rat was placed into the center
of an open-ﬁeld arena (a circular wooden box with a diameter of
100 cm and 40 cm high, with ﬂoor divided into 19 regions). Rats
were assessed individually for 5 min, while four parameters were
analyzed: (i) latency to start the movement (time to leave the inner
circle, in s), (ii) locomotion frequency (number of square crossed
with four paws), (iii) rearing frequency (number of times the ani-
mal  stood on their hind paws) and (iv) immobility time (lack of
movement during testing, in s). The apparatus was cleaned with a
5% ethanol solution before behavioral testing to eliminate possible
bias due to odors left by previous rat.
Rotarod activity test
In order to quantify motor deﬁciency, the rotarod test was  used
at a ﬁxed speed, according to Monville et al. (2006). To perform this
test, the animal was placed with all four paws on a bar with a diam-
eter of 7 cm and set 25 cm above the ﬂoor. The bar rotated at a speed
of 25 rpm. Before being submitted to the different treatments, the
rats were trained in two sessions of 180 s each for habituation. Ani-
mals were placed on the rotating bar and the time spent on the
rotating bar was recorded. A cut-off time of 180 s was  maintained
throughout the experiment. The average results were recorded as
time of fall.
Biochemical analysis
After behavioral observations, animals were immediately anes-
thetized, euthanized by decapitation and their brains removed.
Bilateral substantia nigra, striatum and cortex were dissected,
weighed and homogenized in a Potter–Elvehjem type homoge-
nizer with a tissue homogenate 1× phosphate buffered saline (10%
w/v, PBS) to which was  added butylated hydroxytoluene (0.004%
w/v, BHT) for preventing oxidation of the samples. The homogenate
was centrifuged at 10,000 × g for 30 min  at 4 ◦C and an aliquot of
supernatant was separated for biochemical analysis. Each individ-
ual experiment was carried out in triplicate and repeated two  or
three times.
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PPH radical scavenging activity in vitro
Antioxidant radical scavenging activity was evaluated using
PPH (2,2-diphenyl-1-picrylhydrazyl) radicals (Brand-Williams
t al., 1995). 1 ml  of DPPH solution (30 mM,  in 95% ethanol) was
ncubated with 2.5 ml  of varying concentrations of S. terebinthifolius
xtract (2.5–250 g/ml). The reaction mixture was  shaken well and
ncubated for 30 min  at room temperature, and the absorbance
f the resulting solution was read at 515 nm against a blank.
he radical scavenging activity was measured as an absorbance
ecrease of DPPH and was calculated using the following equation:
Absorbance of control − Absorbance of test) × 100/Absorbance of
ontrol. The synthetic antioxidant butylated hydroxytoluene (BHT)
as included in experiments as a positive control. The EC50 value
or each sample (tree replicates), was calculated from a calibration
urve obtained for the percentage of radical scavenging activ-
ty versus concentration of the sample required to reduce the
bsorbance of the negative control (DPPH solution) by 50%. The
HT curve antioxidant was y = 15.695 ln(x) + 16.477 (R2 = 0.9544).
he S. terebinthifolius extract curve was y = 18.322 ln(x) − 24.936
R2 = 0.9026).
easurement of lipid peroxidation in vivo
The quantitative measurement of lipid peroxidation in the subs-
antia nigra, striatum and cortex was performed according to the
ethod described by Buege and Aust (1978). The amount of malon-
ialdehyde (MDA) of lipid peroxidation was measured by reaction
ith thiobarbituric acid. Brieﬂy, aliquots (500 l) of supernatant
ere placed in test tubes and added to 1 ml  of TBA reagent:
.38% (w/w) TBA, 250 ml  of 1 N hydrochloric acid, 15% (w/w)  of
richloroacetic acid and 20 ml  of 2% (w/v) ethanolic BHT. The solu-
ion was shaken and heated to 100 ◦C for 15 min, followed by
ooling in an ice bath. Then, 1.5 ml  of n-butanol was  added. The
ixture was shaken and centrifuged to 3000 × g for 20 min. After
entrifugation, the upper layer was collected and assessed with a
pectrophotometer (CARY 3E UV–Visible Spectrophotometer Var-
an, Inc. Brazil) at 532 nm.  Results of TBARS of substantia nigra,
triatum and cortex were expressed as nmol MDA/mg protein using
 standard curve generated with different concentrations of 1,1,3,3-
etramethoxypropane solution.
tatistical analysis
Data were expressed as mean ± standard error of mean (SEM).
he difference between groups was analyzed by one-way analy-
is of variance (ANOVA) followed by post hoc Newman–Keuls test.
he comparisons were carried out by GraphPad Prism® 5.0 and
igniﬁcant at p ≤ 0.05.
esults
igh performance liquid chromatography (HPLC) analysis
From the comparison of retention times with extract standards
reviously injected into the HPLC, it was possible to conﬁrm that, S.
erebinthifolius sample demonstrated the presence of phenolic acids
gallic acid, 4.66 min; ellagic acid, 7.51 min) and also ﬂavonoids
catechin, 10.24 min; epicatechin 19.05 min) (Fig. 1).
ffects of S. terebinthifolius on behavioral testsRotenone administration (3 mg/kg, s.c.)  during 7 days signif-
cantly reduced the frequencies of locomotion and rearing and
ncreased the time of immobility and latency to start the move-
ent in the open ﬁeld test. Pre-treatment with the stem barkFig. 1. Chromatogram of Schinus terebinthifolius stem bark detected at 278 nm.
Peaks: gallic acid (Rt = 4.66), catechin (7.51), epicatechin (10.24) and ellagic acid
(Rt  = 19.05) obtained by HPLC method.
(150, 300 and 600 mg/kg) signiﬁcantly improved locomotor activ-
ity and rearing and decreased the time of immobility and latency
to start the movement when compared to rotenone animals. How-
ever, the lower dose of the extract (150 mg/kg) was unable to
prevent the rotenone-induced locomotor deﬁcits in the open ﬁeld
test (Fig. 2a–d).
On rotarod test, rotenone administration (3 mg/kg, s.c.) induced
a signiﬁcant decrease in the time of permanency of the animals
compared with control rats during the observation in the appa-
ratus. Daily pre-treatment of 300 and 600 mg/kg doses was able
to increase the time of permanency in comparison to rotenone
group. However, the lower dose of the extract was  unable to pre-
vent the rotentone-induced locomotor deﬁcits in the open ﬁeld test
(Fig. 3).
Reduction of 2,2-diphenyl-1-picrylhydrazyl radical in vitro
Signiﬁcant DPPH radical scavenging activity was evident
in all concentrations tested of S. terebinthifolius stem bark
(1–250 /ml). The extract was  able to reduce the stable free rad-
ical DPPH to the yellow-colored 1,1-diphenyl-2-picrylhydrazyl
with an EC50 12.176 ± 0.077 g/ml. Under similar conditions, the
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ynthetic antioxidant BHT showed EC50 25.768 ± 0.147 g/ml.
his activity was about 2.1 times smaller when compared to
. terebinthifolius.
easurement of lipid peroxidation in vivo (TBARS)
Rotenone administration (3 mg/kg) during 7 days provoked an
ncrease on oxidative stress as indicated by the signiﬁcant increase
f MDA  concentrations in substantia nigra, striatum and cortex
hen compared to control group. However, the pre-treatment with
ll doses of S. terebinthifolius was able to inhibit the lipid peroxida-
ion in comparison to rotenone animals (Fig. 4a–c). in rats before rotenone (3 mg/kg, s.c.) administration. (a) Total ambulatory activity,
lues are expressed as mean ± S.E.M. (n = 10/group). One-way ANOVA followed by
Discussion
This report showed the neuroprotective effect of S. tere-
binthifolius in Parkinson’s disease using the model of rotenone
subcutaneous administration during 7 days. All doses of S. tere-
binthifolius (150, 300 and 600 mg/kg) signiﬁcantly prevented motor
deﬁcits in the open ﬁeld and rotarod tests, and mainly, was able to
inhibit the oxidative stress induced by systemic rotenone adminis-
tration observed in in vivo TBARS method. It was also demonstrated
the in vitro antioxidant effect of S. terebinthifolius, as well its mainly
compounds in HPLC method. The antioxidant activity of the extract
was also measured in the DPPH radical assay, which primarily eval-
uates proton radical-scavenging ability.
Rotenone is a potent inhibitor of complex I (NADH:
ubiquinoneoxidoreductase) of the mitochondrial electron trans-
port chain. In rats, this toxin causes a syndrome that replicates
both neuropathological ﬁndings and behavioral symptoms of
Parkinson’s disease. Application of low doses of rotenone in vitro
and in vivo have been shown to affect many of the mechanisms
involved in the pathogenesis of Parkinson’s disease, such as altered
calcium signaling, induction of oxidative stress and apoptosis,
loss of tyrosine hydroxlase, proteasomal dysfunction, nigral iron
accumulation and the formation of ﬁbrillar cytoplasmic inclusions
that contain ubiquitin and -synuclein (von Wrangel et al., 2015).
Sherer et al. (2003) also showed that the exposure to low doses
of rotenone (2–3 mg/kg/day) caused highly selective nigrostriatal
dopaminergic lesion. A common feature of all toxin-induced
models of Parkinson’s disease is their ability to produce an
oxidative stress and to cause cell death in dopamine neuronal
populations that reﬂect what is seen in Parkinson’s disease (Blesa
et al., 2012). Markers of oxidative stress are typically found infrom patients with Parkinson’s disease, indicating that indeed
oxidative stress is a key factor in pathogenesis. Malondialde-
hyde (MDA) is a speciﬁc marker of lipid peroxidation, which is
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argely a result of the peroxidation of polyunsaturated fatty acids
ith more than two double bonds (Sanders and Greenamyre,
013).
In our study, administration of rotenone promoted increased
evels of MDA  in substantia nigra, striatum and cortex, suggest-
ng an increased lipid peroxidation and, thus, oxidative stress.
n this way, there was an increase in brain MDA  levels (an
ndicator of lipid peroxidation due to free radicals) which was
nhibited by the administration of stem bark of all doses of S.
erebinthifolius, suggesting its antioxidant action. Indeed, recently
osta et al. (2015) shown that extract from different tissues of
. terebinthifolius present antioxidant activity by DPPH radical
ssay. Abdou et al. (2015) investigated the curative and pro-
ective effects of S. terbenthifolius ethanolic extract (350 mg/kg,
.o.) against CCl4-induced acute hepatotoxicity in rats and shown
hat the administration signiﬁcantly reinstated the antioxidant
apacity. Oxidative stress due to an increase in free radical gen-
ration or an impaired endogenous antioxidant mechanism is anrmacognosia 26 (2016) 240–245
important factor that had been implicated in various neurodegen-
erative diseases (Sanders and Greenamyre, 2013; Solanki et al.,
2015).
The brain is highly susceptible to free radical damage because
of its high utilization of oxygen and the presence of a relatively
low concentration of antioxidant enzymes and free radical scaven-
gers. There is a growing interest in establishing therapeutic and
dietary strategies to combat oxidative stress induced damage to
the central nervous system (Gao et al., 2012; Virmani et al., 2013).
Studies in humans and animals have suggested that ﬂavonoids,
a large group of polyphenolic compounds found in fruits and
vegetables are capable of counteracting neuronal injury, thereby
delaying the progression of neurodegenerative diseases, motivat-
ing researches efforts to identify the mechanisms of neuronal death
as well to discover new compounds to control them (Dutta and
Mohanakumar, 2015; Chen et al., 2015; Solanki et al., 2015; Renaud
et al., 2015).
The major compounds of stem bark of S. terebinthifolius Raddi
are ﬂavonoids (cathechin and epicatechin) and phenolics acids (gal-
lic acid and ellagic acid). Catechins are powerful antioxidants and
free radical scavengers in vitro assays and in vivo models (Srividhya
et al., 2009; Solanki et al., 2015). It has been found that catechins
have much higher antioxidant activity in comparison to vitamins
C and E in vitro. The chemical structures have been contributed
to this effect to chelate metal ions, prevent the generation of free
radicals, allow the displacement of electrons and provide high reac-
tivity to eliminate the free radicals (Mandel et al., 2006; Khan and
Mukhtar, 2007; Senthil, 2008). Furthermore, the catechins and epi-
catechins were also able to indirectly modulate expression of some
protective enzymes antioxidants (Hidgon and Frei, 2003; Weinreb
et al., 2004). The chronic treatment with catechins prevented the
decline in the activity of SOD and GSH enzymes in the serum of
old mice, preventing also signiﬁcantly increased TBARS in the hip-
pocampus of these animals (Abd El Mohsen et al., 2002; Mandel
et al., 2006). Otherwise, gallic acid and ellagic acid are hydrolyzed
tannins of natural products found in abundance in grapes, tea, fruit
and wine (Singh et al., 2004). These acids were able to reduce
the production of ROS and superoxide, such as hydrogen perox-
ide, hydroxyl radicals and hypochlorous acid; also due to their
antimutagenic and anticarcinogenic activities (Kim, 2007). In the
cognitive impairment induced by another animal model of Parkin-
son’s disease in animals, 6-OHDA, the treatment with gallic acid
signiﬁcantly reduced the level of TBARS in the rat brains (Kim,
2007).
In conclusion, the results of this study conﬁrm that the subcuta-
neous administration of rotenone in rats induces neurobehavioral
and biochemical changes mimicking those observed in Parkinson’s
disease. Treatment of rats with S. terebinthifolius produced signif-
icant neuroprotection probably mediated through its antioxidant
activity. Taken together, our data suggested neuroprotective effects
of S. terebinthifolius Raddi, probably mediated through its antiox-
idant activity. Thus, the present work brought out new insights
for the treatment of neurodegenerative diseases and highlighted
the pharmacological properties for Parkinson’s disease and other
neurodegenerative pathologies.
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